DIFFICULTIES OF MINIMAL RESIDUAL DISEASE MONITORING BY NESTED PCR IN TEL-AML1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN

被引：0
|
作者：
Colita, A. [1 ]
Radu, L. E. [1 ]
Dumitru, J. [2 ]
Dragomir, M. [2 ]
Jardan, C. [3 ]
Gheorghe, A. [4 ]
Coriu, D. [1 ]
Arion, C. [1 ]
机构：
[1] Fundeni Clin Inst, Bucharest, Romania
[2] Fundeni Clin Inst, Mol Biol Lab, Bucharest, Romania
[3] Fundeni Clin Inst, Genet Lab, Bucharest, Romania
[4] Fundeni Clin Inst, Immunophenotyping Lab, Bucharest, Romania
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1406
引用
收藏
页码：549 / 549
页数：1
相关论文
共 50 条
  • [1] Quantitative monitoring of minimal residual disease in childhood acute lymphoblastic leukemia using TEL-AML1 fusion transcript as a marker
    Zhao Xiaoxi
    Gao Chao
    Cui Lei
    Li Weijing
    Liu Shuguang
    Zhang Ruidong
    Liu Yi
    Wu Minyuan
    Li Zhigang
    儿科学（英文）, 2018, 2 (04)
  • [2] Quantitative monitoring of minimal residual disease in childhood acute lymphoblastic leukemia using TEL-AML1 fusion transcript as a marker
    Zhao, Xiaoxi
    Gao, Chao
    Cui, Lei
    Li, Weijing
    Liu, Shuguang
    Zhang, Ruidong
    Liu, Yi
    Wu, Minyuan
    Li, Zhigang
    PEDIATRIC INVESTIGATION, 2018, 2 (04) : 223 - 229
  • [3] Quantification of TEL-AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia
    Drunat, S
    Olivi, M
    Brunie, G
    Grandchamp, B
    Vilmer, E
    Bièche, I
    Cavé, H
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (02) : 281 - 289
  • [4] Molecular detection of TEL-AML1 transcripts as a diagnostic tool and for monitoring of minimal residual disease in B-lineage childhood acute lymphoblastic leukemia
    Park, HJ
    Lee, KE
    Um, JM
    Choe, SY
    Chi, XZ
    Lee, JA
    Shin, HY
    Ahn, HS
    Bae, SC
    MOLECULES AND CELLS, 2000, 10 (01) : 90 - 95
  • [5] Evaluation of minimal residual disease (MRD) by quantification of TEL-AML1 transcripts is a powerful prognostic tool in children with t(12;21) positive acute lymphoblastic leukemia (ALL)
    Cayuela, JM
    Ballerini, P
    Romeo, M
    Asnafi, V
    Auclerc, MF
    Fund, X
    Delabesse, E
    Bastard, C
    Gabert, J
    Vanier, JP
    Lejars, O
    Debre, M
    Pautard, B
    Michel, G
    Leblanc, T
    Leverger, G
    Chevret, S
    Macintyre, E
    Baruchel, A
    BLOOD, 2004, 104 (11) : 95A - 96A
  • [6] Chemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells
    Narla, RK
    Navara, C
    Sarquis, M
    Uckun, FM
    LEUKEMIA & LYMPHOMA, 2001, 41 (5-6) : 615 - +
  • [7] TEL-AML1 POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA-SINGLE CENTRE EXPERIENCE
    Kourti, M.
    Sgouropoulou, V.
    Athanassiadou, A.
    Papakonstantinou, E.
    Taparkou, A.
    Koliouskas, D.
    HAEMATOLOGICA, 2016, 101 : 664 - 664
  • [8] TEL-AML1 fusion in relapsed childhood acute lymphoblastic leukemia
    Seeger, K
    Buchwald, D
    Peter, A
    Taube, T
    von Stackelbere, A
    Schmitt, G
    Henze, G
    BLOOD, 1999, 94 (01) : 374 - 375
  • [9] Minimal residual disease with TEL-AML1 fusion transcript in childhood acute lymphoblastic leukaemia with t(12;21)
    Satake, N
    Kobayashi, H
    Tsunematsu, Y
    Kawasaki, H
    Horikoshi, Y
    Koizumi, S
    Kaneko, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (03) : 607 - 611
  • [10] OUTCOME AND PROGNOSTIC FACTORS FOR TEL-AML1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN KOREAN CHILDREN: A SINGLE INSTITUTION STUDY
    Lee, J. W.
    Jang, P. S.
    Chung, N. G.
    Jeong, D. C.
    Cho, B.
    Kim, H. K.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S261 - S261
12345